Laxante
Natural health product licensed in Canada
- Other names
- Laxante Tablet, Laxwill, Sennawil, Swiss Lax Tablet
- Licence holder
- Wilshire Labs Private Limited
- NPN or DIN-HM
- 80105381
- Status
- Active licence
- Licence date
- 16 October 2020
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Senna alexandrina Source : Feuille Potency : 20 % Sennoside B | 70 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce Source : Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
Non-medicinal ingredients
Lécithine, Poly(alcool vinylique), Poly(éthylène glycol), Oxyde de fer noir, Croscarmellose de sodium, Lactose, Oxyde de fer jaune, Talcum, Stéarate de magnésium, Cellulose microcristalline, Amidon prégélatinisé
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 2 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
(Used in Herbal Medicine as a) stimulant laxative to promote bowel movement and short-term relief of occasional constipation. Source of/An antioxidant. Source of/An antioxidant that helps fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Peppermint is traditionally used in Herbal Medicine to help relieve flatulent dyspepsia (carminative). Ginger is traditionally used in Herbal Medicine to help relieve digestive upset/disturbances including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia and flatulent colic (carminative).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80105381
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.